Northern Trust’s Vertex Pharmaceuticals VRTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1.18B | Buy |
|
|||||
|
2025
Q1 | $1.27B | Sell |
|
|||||
|
2024
Q4 | $1.1B | Buy |
|
|||||
|
2024
Q3 | $1.1B | Sell |
|
|||||
|
2024
Q2 | $1.19B | Sell |
|
|||||
|
2024
Q1 | $1.08B | Sell |
|
|||||
|
2023
Q4 | $1.09B | Sell |
|
|||||
|
2023
Q3 | $978M | Buy |
|
|||||
|
2023
Q2 | $944M | Sell |
|
|||||
|
2023
Q1 | $875M | Sell |
|
|||||
|
2022
Q4 | $823M | Sell |
|
|||||
|
2022
Q3 | $836M | Sell |
|
|||||
|
2022
Q2 | $828M | Buy |
|
|||||
|
2022
Q1 | $754M | Sell |
|
|||||
|
2021
Q4 | $639M | Sell |
|
|||||
|
2021
Q3 | $543M | Buy |
|
|||||
|
2021
Q2 | $599M | Sell |
|
|||||
|
2021
Q1 | $640M | Sell |
|
|||||
|
2020
Q4 | $714M | Sell |
|
|||||
|
2020
Q3 | $843M | Buy |
|
|||||
|
2020
Q2 | $865M | Buy |
|
|||||
|
2020
Q1 | $681M | Buy |
|
|||||
|
2019
Q4 | $622M | Sell |
|
|||||
|
2019
Q3 | $500M | Buy |
|
|||||
|
2019
Q2 | $540M | Buy |
|
|||||
|
2019
Q1 | $535M | Buy |
|
|||||
|
2018
Q4 | $477M | Buy |
|
|||||
|
2018
Q3 | $536M | Sell |
|
|||||
|
2018
Q2 | $476M | Sell |
|
|||||
|
2018
Q1 | $458M | Sell |
|
|||||
|
2017
Q4 | $426M | Sell |
|
|||||
|
2017
Q3 | $440M | Buy |
|
|||||
|
2017
Q2 | $349M | Buy |
|
|||||
|
2017
Q1 | $296M | Buy |
|
|||||
|
2016
Q4 | $195M | Sell |
|
|||||
|
2016
Q3 | $259M | Buy |
|
|||||
|
2016
Q2 | $253M | Buy |
|
|||||
|
2016
Q1 | $240M | Buy |
|
|||||
|
2015
Q4 | $365M | Sell |
|
|||||
|
2015
Q3 | $327M | Sell |
|
|||||
|
2015
Q2 | $398M | Buy |
|
|||||
|
2015
Q1 | $371M | Sell |
|
|||||
|
2014
Q4 | $380M | Buy |
|
|||||
|
2014
Q3 | $357M | Buy |
|
|||||
|
2014
Q2 | $278M | Sell |
|
|||||
|
2014
Q1 | $227M | Buy |
|
|||||
|
2013
Q4 | $222M | Sell |
|
|||||
|
2013
Q3 | $228M | Buy |
|
|||||
|
2013
Q2 | $187M | Buy |
|